Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(Suppl 6):3–7. doi: 10.1002/clc.4960231103

Multiple Mechanisms of Thrombosis Complicating Atherosclerotic Plaques

Peter Libby 1,
PMCID: PMC6655212  PMID: 11129684

Abstract

Atherosclerosis is a highly prevalent disorder and remains a leading cause of morbidity and mortality in the United States. Recent advances in vascular biology have led to a better understanding of the mechanisms underlying atherogenesis. The central role played by plaque disruption, and by adhesion, activation, and aggregation of platelets that trigger activation of the coagulation cascade in the pathogenesis of acute thrombotic events is also better understood. Combination antithrombotic therapy targeting various platelet activation mechanisms and the coagulation cascade may help optimize the management of atherosclerosis.

Keywords: acute coronary syndromes, plaque, thrombosis, platelet

Full Text

The Full Text of this article is available as a PDF (568.5 KB).

References

  • 1. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, Buring JE, Hennekens CH: The primary prevention of myocardial infarction. N Engl J Med 1992; 326: 1406–1416 [DOI] [PubMed] [Google Scholar]
  • 2. Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE, Willett WC: Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000; 343: 530–537 [DOI] [PubMed] [Google Scholar]
  • 3. Lee RT, Libby P: The unstable atheroma. Arterioscler Thromb Vase Biol 1997; 17: 1859–1867 [DOI] [PubMed] [Google Scholar]
  • 4. Libby P, Sukhova G, Lee RT, Liao JK: Molecular biology of atherosclerosis. Int J Cardiol 1997; 62 (suppl 2): S23–S29 [DOI] [PubMed] [Google Scholar]
  • 5. Kinlay S, Selwyn AP, Libby P, Ganz P: Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998; 32 (suppl 3): S62–S66 [PubMed] [Google Scholar]
  • 6. Shah PK: New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol 1997; 79: 17–23 [DOI] [PubMed] [Google Scholar]
  • 7. Libby P, Mach F, Schonbeck U, Bourcier T, Aikawa M: Regulation of the thrombotic potential of atheroma. Thromb Haemost 1999; 82: 736–741 [PubMed] [Google Scholar]
  • 8. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844–2850 [DOI] [PubMed] [Google Scholar]
  • 9. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995; 92: 657–671 [DOI] [PubMed] [Google Scholar]
  • 10. Davies MJ: A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990; 82 (3 suppl): II38–II46 [PubMed] [Google Scholar]
  • 11. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–809 [DOI] [PubMed] [Google Scholar]
  • 12. Moreno PR, Bernardi VH, Lopez‐Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT: Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell‐mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94: 3090–3097 [DOI] [PubMed] [Google Scholar]
  • 13. Hansson GK, Jonasson L, Seifert PS, Stemme S: Immune mechanisms in atherosclerosis. Arteriosclerosis 1989; 9: 567–578 [DOI] [PubMed] [Google Scholar]
  • 14. Stemme S, Holm J, Hansson GK: T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA‐1. Arterioscler Thromb 1992; 12: 206–211 [DOI] [PubMed] [Google Scholar]
  • 15. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ: Immune regulation by CD40 and its ligand GP39. Ann Rev Immunol 1996; 14: 591–617 [DOI] [PubMed] [Google Scholar]
  • 16. Mach F, Schönbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40‐CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 1931–1936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394: 200–203 [DOI] [PubMed] [Google Scholar]
  • 18. Mach F, Schönbeck U, Bonnefoy JY, Pober JS, Libby P: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor. Circulation 1997; 96: 396–399 [DOI] [PubMed] [Google Scholar]
  • 19. Bizzozero G: On a New Blood Particle and Its Role in Thrombosis and Blood Coagulation [in German]. Bern, Switzerland: Huber; 1982. [German text reproduced from Vichow's Archiv für pathologische Anatomie und Physiologie und für klinische Medicine 90:261–332 (1882); translated into English by Eugen A. Beck.] [Google Scholar]
  • 20. Coller BS: Platelets in cardiovascular thrombosis and thrombolysis In The Heart and Cardiovascular System. 2nd. Edition (Eds. Fozzard HA, Jennings RB, Haber E, Katz AM.), p. 219–233. New York: Raven Press, 1991. [Google Scholar]
  • 21. Lefkovits J, Plow EF, Topol EI: Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553–1559 [DOI] [PubMed] [Google Scholar]
  • 22. Ambrose JA, Weinrauch M: Thrombosis in ischemic heart disease. Arch Intern Med 1996; 156: 1382–1394 [PubMed] [Google Scholar]
  • 23. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA: Angioscopic evaluation of coronary‐artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287–291 [DOI] [PubMed] [Google Scholar]
  • 24. Schafer AI: Coagulation cascade: An overview In Thrombosis and Hemorrhage. (Eds. Loscalzo J, Schafer AI.), p. 3–12. Boston: Blackwell Scientific Publications, 1994. [Google Scholar]
  • 25. Schafer AI: Antiplatelet therapy. Am J Med 1996; 101: 199–209 [DOI] [PubMed] [Google Scholar]
  • 26. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators : Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: A pilot study. Circulation 1997; 96: 769–777 [DOI] [PubMed] [Google Scholar]
  • 27. Sharis PJ, Cannon CP, Loscalzo J: The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998; 129: 394–405 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES